Cancer research (Post Doc Joe Ibrahim)
Genome-wide Identification of Universal and Type-specific DNA Methylation Markers for the Most Common Cancer Types.
With an estimated 8.8 million deaths yearly, the cancer burden weighs heavily on populations globally. Early detection remains paramount for improved patient prognosis and disease management. In this respect, DNA methylation holds great promise as a cancer marker, and combined with liquid biopsies, is potentially a major enhancement over currently used detection methods. Several biomarker studies have focused on identifying cancer types individually, yet highly effective pan- and type-specific cancer markers are still lacking. This project aims to develop a computational and statistical framework to identify both pan- and type-specific methylation cancer detection markers, genome-wide, from public and clinical datasets. These markers would serve as targets for a novel minimally-invasive methylation assay. Moreover, we aim to develop the bioinformatics infrastructure required for downstream data analysis and assay validation in the context of liquid biopsies.
PhD student: Joe Ibrahim
Supervisors: Guy Van Camp & Ken Op de Beeck












Ken Op de Beeck
Joe Ibrahim
Ellen Steenackers
Anne Schepers
Ana Regina De Abreu
Janah Vandenhoeck
Eef van den Borst
Nele De Meulenaere
Jana Thys
Ayla Wyninckx
Siddhard Chhajlani
Jonas Dahnoun
Leandro Fernandes
Amirhosein Kalhor
Lien Hillen